Literature DB >> 17181398

Enhanced bone regeneration associated with decreased apoptosis in mice with partial HIF-1alpha deficiency.

David E Komatsu1, Marta Bosch-Marce, Gregg L Semenza, Michael Hadjiargyrou.   

Abstract

UNLABELLED: HIF-1alpha activates genes under hypoxia and was hypothesized to regulate bone regeneration. Surprisingly, HIF-1alpha+/- fracture calluses are larger, stronger, and stiffer than HIF-1alpha+/+ calluses because of decreased apoptosis. These data identify apoptosis inhibition as a means to enhance bone regeneration.
INTRODUCTION: Bone regeneration subsequent to fracture involves the synergistic activation of multiple signaling pathways. Localized hypoxia after fracture activates hypoxia-inducible factor 1alpha (HIF-1alpha), leading to increased expression of HIF-1 target genes. We therefore hypothesized that HIF-1alpha is a key regulator of bone regeneration.
MATERIALS AND METHODS: Fixed femoral fractures were generated in mice with partial HIF-1alpha deficiency (HIF-1alpha+/-) and wildtype littermates (HIF-1alpha+/+). Fracture calluses and intact contralateral femurs from postfracture days (PFDs) 21 and 28 (N=5-10) were subjected to microCT evaluation and four-point bending to assess morphometric and mechanical properties. Molecular analyses were carried out on PFD 7, 10, and 14 samples (N=3) to determine differential gene expression at both mRNA and protein levels. Finally, TUNEL staining was performed on PFD 14 samples (N=2) to elucidate differential apoptosis.
RESULTS: Surprisingly, fracture calluses from HIF-1alpha+/- mice exhibited greater mineralization and were larger, stronger, and stiffer. Microarray analyses focused on hypoxia-induced genes revealed differential expression (between genotypes) of several genes associated with the apoptotic pathway. Real-time PCR confirmed these results, showing higher expression of proapoptotic protein phosphatase 2a (PP2A) and lower expression of anti-apoptotic B-cell leukemia/lymphoma 2 (BCL2) in HIF-1alpha+/+ calluses. Subsequent TUNEL staining showed that HIF-1alpha+/+ calluses contained larger numbers of TUNEL+ chondrocytes and osteoblasts than HIF-1alpha+/- calluses.
CONCLUSIONS: We conclude that partial HIF-1alpha deficiency results in decreased chondrocytic and osteoblastic apoptosis, thereby allowing the development of larger, stiffer calluses and enhancing bone regeneration. Furthermore, apoptosis inhibition may be a promising target for developing new treatments to accelerate bone regeneration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17181398      PMCID: PMC2268762          DOI: 10.1359/jbmr.061207

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  50 in total

1.  HIF-1alpha controls extracellular matrix synthesis by epiphyseal chondrocytes.

Authors:  David Pfander; Thorsten Cramer; Ernestina Schipani; Randall S Johnson
Journal:  J Cell Sci       Date:  2003-05-01       Impact factor: 5.285

2.  Intramyocardial injection of naked DNA encoding HIF-1alpha/VP16 hybrid to enhance angiogenesis in an acute myocardial infarction model in the rat.

Authors:  Kou Gi Shyu; Mei Ti Wang; Bao Wei Wang; Chih Chuna Chang; Jyh Gang Leu; Peiliang Kuan; Hang Chang
Journal:  Cardiovasc Res       Date:  2002-06       Impact factor: 10.787

3.  Wnt signaling activation during bone regeneration and the role of Dishevelled in chondrocyte proliferation and differentiation.

Authors:  Nan Zhong; Robert P Gersch; Michael Hadjiargyrou
Journal:  Bone       Date:  2006-02-03       Impact factor: 4.398

Review 4.  Fracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation.

Authors:  Louis C Gerstenfeld; Dennis M Cullinane; George L Barnes; Dana T Graves; Thomas A Einhorn
Journal:  J Cell Biochem       Date:  2003-04-01       Impact factor: 4.429

Review 5.  Phosphatases in apoptosis: to be or not to be, PP2A is in the heart of the question.

Authors:  Christine Van Hoof; Jozef Goris
Journal:  Biochim Biophys Acta       Date:  2003-05-12

6.  2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF.

Authors:  Nicola J Mabjeesh; Daniel Escuin; Theresa M LaVallee; Victor S Pribluda; Glenn M Swartz; Michelle S Johnson; Margaret T Willard; Hua Zhong; Jonathan W Simons; Paraskevi Giannakakou
Journal:  Cancer Cell       Date:  2003-04       Impact factor: 31.743

7.  Transcriptional profiling of bone regeneration. Insight into the molecular complexity of wound repair.

Authors:  Michael Hadjiargyrou; Frank Lombardo; Shanchuan Zhao; William Ahrens; Jungnam Joo; Hongshik Ahn; Mark Jurman; David W White; Clinton T Rubin
Journal:  J Biol Chem       Date:  2002-06-07       Impact factor: 5.157

8.  Adenoviral VEGF-A gene transfer induces angiogenesis and promotes bone formation in healing osseous tissues.

Authors:  Tatu Tarkka; Annina Sipola; Timo Jämsä; Ylermi Soini; Seppo Ylä-Herttuala; Juha Tuukkanen; Timo Hautala
Journal:  J Gene Med       Date:  2003-07       Impact factor: 4.565

Review 9.  Is HIF-1alpha a pro- or an anti-apoptotic protein?

Authors:  Jean-Pascal Piret; Denis Mottet; Martine Raes; Carine Michiels
Journal:  Biochem Pharmacol       Date:  2002-09       Impact factor: 5.858

10.  The fate of soft callus chondrocytes during long bone fracture repair.

Authors:  Joanna L Ford; Derek E Robinson; Brigitte E Scammell
Journal:  J Orthop Res       Date:  2003-01       Impact factor: 3.494

View more
  18 in total

1.  Inactivation of Vhl in osteochondral progenitor cells causes high bone mass phenotype and protects against age-related bone loss in adult mice.

Authors:  Tujun Weng; Yangli Xie; Junlan Huang; Fengtao Luo; Lingxian Yi; Qifen He; Di Chen; Lin Chen
Journal:  J Bone Miner Res       Date:  2014-04       Impact factor: 6.741

2.  Identification and Characterization of a Synthetic Osteogenic Peptide.

Authors:  David E Komatsu; Michael Hadjiargyrou; Sardar M Z Udin; Nicholas A Trasolini; Srinivas Pentyala
Journal:  Calcif Tissue Int       Date:  2015-08-29       Impact factor: 4.333

3.  Genetic association of angiogenesis- and hypoxia-related gene polymorphisms with osteonecrosis of the femoral head.

Authors:  Jung Min Hong; Tae Ho Kim; Hyun Ju Kim; Eui Kyun Park; Eun Kyoung Yang; Shin Yoon Kim
Journal:  Exp Mol Med       Date:  2010-05-31       Impact factor: 8.718

Review 4.  A central role for hypoxic signaling in cartilage, bone, and hematopoiesis.

Authors:  Erinn B Rankin; Amato J Giaccia; Ernestina Schipani
Journal:  Curr Osteoporos Rep       Date:  2011-06       Impact factor: 5.096

Review 5.  The convergence of fracture repair and stem cells: interplay of genes, aging, environmental factors and disease.

Authors:  Michael Hadjiargyrou; Regis J O'Keefe
Journal:  J Bone Miner Res       Date:  2014-11       Impact factor: 6.741

6.  Angiogenesis in bone regeneration.

Authors:  Kurt D Hankenson; Michael Dishowitz; Chancellor Gray; Mara Schenker
Journal:  Injury       Date:  2011-04-12       Impact factor: 2.586

7.  Hypoxia-inducible factor regulates osteoclast-mediated bone resorption: role of angiopoietin-like 4.

Authors:  Helen J Knowles; Anne-Marie Cleton-Jansen; Eberhard Korsching; Nicholas A Athanasou
Journal:  FASEB J       Date:  2010-07-28       Impact factor: 5.191

8.  β-arrestin-selective G protein-coupled receptor agonists engender unique biological efficacy in vivo.

Authors:  Diane Gesty-Palmer; Ling Yuan; Bronwen Martin; William H Wood; Mi-Hye Lee; Michael G Janech; Lam C Tsoi; W Jim Zheng; Louis M Luttrell; Stuart Maudsley
Journal:  Mol Endocrinol       Date:  2013-01-11

9.  Modulation of Wnt signaling influences fracture repair.

Authors:  David E Komatsu; Michelle N Mary; Robert Jason Schroeder; Alex G Robling; Charles H Turner; Stuart J Warden
Journal:  J Orthop Res       Date:  2010-07       Impact factor: 3.494

10.  Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment.

Authors:  Lauren K Dunn; Khalid S Mohammad; Pierrick G J Fournier; C Ryan McKenna; Holly W Davis; Maria Niewolna; Xiang Hong Peng; John M Chirgwin; Theresa A Guise
Journal:  PLoS One       Date:  2009-09-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.